Cost-Utility Analysis of IEV Drug Regimen Versus ESHAP Drug Regimen for the Patients With Relapsed and Refractory Hodgkin and Non-Hodgkin’s Lymphoma in Iran

BACKGROUND: Chemotherapy for lymph nodes cancer is often composed of several drugs that are used in a treatment program. OBJECTIVES: The aim of this study was to perform a cost-utility analysis of IEV regimen (ifosfamide, epirubicin and etoposide) versus ESHAP regimen (etoposide, methylprednisolone,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatam, Nahid, Dehghani, Mehdi, Habibian, Mostafa, Jafari, Abdosaleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667232/
https://www.ncbi.nlm.nih.gov/pubmed/26634115
http://dx.doi.org/10.17795/ijcp-4061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667232/
https://www.ncbi.nlm.nih.gov/pubmed/26634115
http://dx.doi.org/10.17795/ijcp-4061

Ejemplares similares